Kyleena

Levonorgestrel, the active ingredient in Kyleena, is a progestogen presented as a 52 mg intrauterine system for intrauterine use. It provides hormonal contraception for women of reproductive age, delivering continuous levonorgestrel release to prevent pregnancy. GNH USA supplies Kyleena as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kyleena, a levonorgestrel‑releasing intrauterine system, is used within the hormonal contraceptive pathway to prevent pregnancy.

- Contraception (up to 5 years): provides highly effective reversible birth control for up to five years of use. - Family planning: offers long‑term, maintenance‑free contraception without daily dosing. - Hormonal contraception: delivers continuous progestogen effect to suppress ovulation and alter cervical mucus.

Common Side Effects: - Irregular vaginal bleeding or spotting. - Amenorrhea (absence of periods). - Pelvic or cramping pain after insertion. - Breast tenderness. - Mood changes or headache.

Serious or Rare Side Effects: - Uterine perforation during insertion. - IUS expulsion. - Pelvic inflammatory infection. - Ectopic pregnancy if contraception fails. - Ovarian cyst formation. - Severe allergic reaction (anaphylaxis).

Before insertion, clinicians should assess patient suitability and counsel on risks. - Pregnancy contraindicated: avoid use in pregnant women. - Uterine abnormalities: screen for fibroids, malformations, or scarring. - History of pelvic infection: evaluate and treat prior infections. - Smoking over age 35: advise cessation due to increased cardiovascular risk. - Breastfeeding: discuss benefits and alternatives with the prescriber. - Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

Levonorgestrel may interact with drugs that alter its metabolism or hormonal balance.

Major Interactions (Avoid): - Rifampin, carbamazepine, phenytoin, phenobarbital: enzyme inducers that reduce levonorgestrel levels. - St. John’s wort: may decrease contraceptive efficacy.

Moderate Interactions (Monitor Closely): - Antifungal agents such as ketoconazole: may increase hormone concentrations. - Certain antiretrovirals (e.g., efavirenz): may modestly lower effectiveness. - Combined hormonal contraceptives: assess cumulative hormonal exposure. - Hormone‑sensitive conditions (e.g., endometriosis): monitor symptom changes.